Acrivon Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 13/11/2025 | Mar 2024Filed 13/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$18 | −$19 | −$18 | −$21 | −$20 | −$22 | −$19 | −$16 | |
| −$0.43 | −$0.49 | −$0.47 | −$0.55 | −$0.51 | −$0.59 | −$0.52 | −$0.73 | |
| 42 | 39 | 39 | 38 | 38 | 38 | 36 | 23 |
Trend